Lv3
382 积分 2026-02-26 加入
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
2天前
已关闭
Abstract P5-03-09: Evaluating Post-T-DXd Treatment Strategies in HER2-positive Metastatic Breast Cancer
2天前
已关闭
Timing Is of the Essence: Sequencing Immune Checkpoint Blockade and Radiotherapy for Success in Lung Cancer
2天前
已完结
Antibody–drug conjugates in gynaecological cancers: opportunities and challenges
3天前
已完结
Neoadjuvant or Perioperative Chemoimmunotherapy Treatment in Patients with Resectable NSCLC: Still an Open Question. Comments on Marinelli et al. J Thorac Oncol. 2025;20:285–295
5天前
已完结
Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer
6天前
已完结
Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer
6天前
已完结
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
6天前
已完结
Efficacy and safety of consolidative thoracic radiotherapy for Extensive-Stage Small-Cell lung cancer in the era of immunotherapy: A Real-World study
9天前
已完结
Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: A multicentric retrospective analysis
9天前
已完结
皖公网安备34019202002308
